Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2016 1
2017 4
2018 1
2019 3
2020 2
2021 4
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
New anthyarrhythmic drugs for atrial fibrillation.
Matassini MV, Guerra F, Scappini L, Urbinati A, Capucci A. Matassini MV, et al. Among authors: urbinati a. Future Cardiol. 2015;11(6):705-17. doi: 10.2217/fca.15.69. Future Cardiol. 2015. PMID: 26631497 Review.
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.
Januzzi JL, Del Prato S, Rosenstock J, Butler J, Ezekowitz J, Ibrahim NE, Lam CSP, Marwick T, Wilson Tang WH, Liu Y, Mohebi R, Urbinati A, Zannad F, Perfetti R. Januzzi JL, et al. Among authors: urbinati a. Cardiovasc Diabetol. 2024 Feb 1;23(1):49. doi: 10.1186/s12933-024-02135-z. Cardiovasc Diabetol. 2024. PMID: 38302936 Free PMC article.
Is Swimming Safe in Heart Failure? A Systematic Review.
Shah P, Pellicori P, Macnamara A, Urbinati A, Clark AL. Shah P, et al. Among authors: urbinati a. Cardiol Rev. 2017 Nov/Dec;25(6):321-325. doi: 10.1097/CRD.0000000000000154. Cardiol Rev. 2017. PMID: 28767502 Review.
Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy.
Januzzi JL Jr, Butler J, Del Prato S, Ezekowitz JA, Ibrahim NE, Lam CSP, Lewis GD, Marwick TH, Rosenstock J, Tang WHW, Zannad F, Lawson F, Perfetti R, Urbinati A. Januzzi JL Jr, et al. Among authors: urbinati a. Am Heart J. 2023 Feb;256:25-36. doi: 10.1016/j.ahj.2022.11.003. Epub 2022 Nov 11. Am Heart J. 2023. PMID: 36372245 Free article. Clinical Trial.
Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases.
Volpato G, Falanga U, Cipolletta L, Conti MA, Grifoni G, Ciliberti G, Urbinati A, Barbarossa A, Stronati G, Fogante M, Bergonti M, Catto V, Guerra F, Giovagnoni A, Dello Russo A, Casella M, Compagnucci P. Volpato G, et al. Among authors: urbinati a. Medicina (Kaunas). 2021 Mar 25;57(4):308. doi: 10.3390/medicina57040308. Medicina (Kaunas). 2021. PMID: 33805943 Free PMC article. Review.
Compassionate drug use for patients with transthyretin amyloid cardiomyopathy.
Ciliberti G, Urbinati A, Barbarossa A, Stronati G, Silenzi M, Principi S, Falanga U, Capucci A, Casella M, Dello Russo A, Guerra F. Ciliberti G, et al. Among authors: urbinati a. J Cardiovasc Med (Hagerstown). 2021 Oct 1;22(10):792-794. doi: 10.2459/JCM.0000000000001192. J Cardiovasc Med (Hagerstown). 2021. PMID: 34487055 No abstract available.
20 results